New content online! Bone-modifying drugs slow OA progression dlvr.it/T6bLkS

New content online! Adropin inhibits fibrosis in SSc dlvr.it/T6NHRv

New content online! Rethinking antiphospholipid syndrome to guide future management and research dlvr.it/T6NHRW

New content online! Relapsing polychondritis: clinical updates and new differential diagnoses dlvr.it/T6KLWS

New content online! Granzyme serine proteases in inflammation and rheumatic diseases dlvr.it/T6HVtk

New content online! Treat-to-target or treat-to-dissolve strategy to improve gout treatment dlvr.it/T63zqm

#MayIssue | Molecular #biomarkers of post-traumatic #osteoarthritis have potential for monitoring the disease trajectory, as preventative treatment targets, and as indicators of the efficacy.

Read more in this Review:

dlvr.it/T5NrrT

#MayIssue | In this #Perspective , the authors consider the application of the genetically transitional disease model to rheumatic diseases and the potential implications for patient care, genetic counselling and research.

dlvr.it/T3Qqvq

#MayIssue | Learn about low-frequency and rare genetic variants associated with #RheumatoidArthritis in our latest #Review from Vanessa Kronzer, MD and colleagues

dlvr.it/T4hNMB

In our #MayIssue , Peter Nigrovic and colleagues discuss how the joint accumulation model of #RheumatoidArthritis implies a 'rolling window of opportunity' for therapy.

Check out the #Review here:

dlvr.it/T5L8HZ

New content online! Advancing precision rheumatology through tissue and blood profiling dlvr.it/T5Rl8L

New content online! Molecular biomarker approaches to prevention of post-traumatic osteoarthritis dlvr.it/T5NrrT

New content online! Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis dlvr.it/T5L8HZ

Our friends at Nature Reviews Endocrinology are hiring!

New content online! Benralizumab noninferior to mepolizumab for EGPA dlvr.it/T5HkQV

New content online! Author Correction: Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells dlvr.it/T58CXQ

New content online! Author Correction: Proposals for the rheumatological use of JAK inhibitors dlvr.it/T4zJDP

New content online! Time for a new approach to drug development for rare systemic autoinflammatory diseases dlvr.it/T4zJCw

New content online! Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative dlvr.it/T4pNjc